Ivan Horak

Dr. Ivan Horak is a distinguished biotech executive and medical oncologist with more than two decades of experience in the pharmaceutical sector, specializing in the development of oncology drugs.

He holds an MD in Medicine from Kommenius Medical School and has held key positions in various prominent organizations within the industry.

Dr. Horak currently serves as the President of Research and Development at Tessa Therapeutics Ltd, where he supervises the company's research, development, regulatory, and clinical activities.

Previously, he has held leadership roles such as Chief Scientific and Medical Officer at Symphogen, Chief Scientific Officer and Chief Medical Officer at The Global Leaders, Chief Scientific Officer and President of Research and Development at Eznon, Chief Scientific Officer and President of R&D at Enzon Pharmaceuticals, as well as positions at Immunomedics and Pharmacia.

Throughout his career, Dr. Horak has been instrumental in advancing various oncology treatments in clinical settings and has successfully led multiple FDA new drug applications.